In childhood cancer survivors, GH therapy improves height without secondary tumor risk
- OPACC
- Jul 12, 2018
- 1 min read
In childhood cancer survivors, treatment with growth hormone was associated with gains in height vs. untreated control patients without increased risk for diabetes or secondary tumors, according to a meta-analysis published in The Journal of Clinical Endocrinology & Metabolism.
Comments